E 5842

Drug Profile

E 5842

Latest Information Update: 26 Feb 2010

Price : $50

At a glance

  • Originator Esteve
  • Class Antipsychotics; Small molecules; Triazoles
  • Mechanism of Action Opioid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.


Highest Development Phases

  • Discontinued Psychotic disorders

Most Recent Events

  • 24 Jul 2001 Phase-II clinical trials for Psychotic disorders in Europe (SC)
  • 10 Nov 2000 Two clinical studies have been added to the pharmacodynamics section ,
  • 14 Apr 2000 Phase-I clinical trials for Psychotic disorders in Spain (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top